Skip to main content
. Author manuscript; available in PMC: 2013 Feb 24.
Published in final edited form as: J Psychopharmacol. 2008 Sep;22(7):784–791. doi: 10.1177/0269881106082899

Figure 2.

Figure 2

Brain levels of orexin A in juvenile rats (35 days old) neonatally treated with either CLI or SAL. In the pons and hypothalamus, orexin A was significantly decreased in the CLI group (a). Among the cortical areas, thalamus and hippocampus, orexin A levels in the CLI group were significantly decreased only in the frontal cortex (b). **P < 0.005; ***P < 0.001.